Company: SGBAF
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001193125-25-120606
Chunk: 397

Company: SES S.A.
Filing Date: 2025-05-15
Form: 424B3
Chunk 397
---
-----------|-------:|:----|:-------------|-------:|:----|:---------------|:--------|:--|:----|:---------------|------:|:----|:---------------|-------:|
| Two Months Ended February 28, 2022 (Predecessor) |     |            | 18,469 |     |              |    961 |     |                | (1,116  | ) |     |                | 6,480 |     | $              | 24,794 |
| Ten Months Ended December 31, 2022 (Successor)   |     | $          | 24,794 |     |              |  9,858 |     |                | (7,883  | ) |     |                |     — |     | $              | 26,769 |
| Year Ended December 31, 2023 (Successor)         |     | $          | 26,769 |     |              | 12,040 |     |                | (10,484 | ) |     |                |     — |     | $              | 28,325 |
| Year Ended December 31, 2024 (Successor)         |     | $          | 28,325 |     |              | 11,673 |     |                | (12,259 | ) |     |                |     — |     | $              | 27,739 |

| (1) | Reflects fair value adjustments due to the adoption of Fresh Start Accounting. |

(s) Software Development Costs For software sold as part of our equipment sales in connection with our Intelsat CA business, we capitalize software development costs once technological feasibility has been established. Capitalized software development costs are included within “Amortizable intangible assets, net” in our consolidated balance sheets. Such capitalized software costs are amortized on a product-by-productbasis over the remaining estimated economic life of the product, based on the greater of the ratio that current gross revenues for a product bear to the total of current and anticipated future gross revenues for that product or the straight-line method. These amortization costs are presented within “Depreciation and amortization” in our consolidated statements of operations. (t) Research and Development Research and development costs are charged to expense in the period in which they are incurred and totaled $1.4 million, $9.7 million, $14.5 million and $14.4 million for the two months ended